Low Sex-Hormone-Binding Globulin Concentration as Independent Risk Factor for Development of NIDDM: 12-Yr Follow-Up of Population Study of Women in Gothenburg, Sweden

Diabetes ◽  
1991 ◽  
Vol 40 (1) ◽  
pp. 123-128 ◽  
Author(s):  
G. Lindstedt ◽  
P.-A. Lundberg ◽  
L. Lapidus ◽  
H. Lundgren ◽  
C. Bengtsson ◽  
...  
2019 ◽  
Vol 66 (7) ◽  
pp. 637-645 ◽  
Author(s):  
Yuya Fujihara ◽  
Nobuya Hamanoue ◽  
Hiromi Yano ◽  
Makito Tanabe ◽  
Yuko Akehi ◽  
...  

2020 ◽  
Vol 6 (4) ◽  
pp. 425-433
Author(s):  
Yuya Fujihara ◽  
Nobuya Hamanoue ◽  
Yuko Akehi ◽  
Ryoko Motonaga ◽  
Tomoko Tanaka ◽  
...  

2015 ◽  
Vol 17 (6) ◽  
pp. 991 ◽  
Author(s):  
Xue-Jun Shang ◽  
Yi-Qun Gu ◽  
Yi-Hong Yang ◽  
Ming-Jia Zhao ◽  
Shan-Jie Zhou ◽  
...  

2010 ◽  
Vol 6 ◽  
pp. S473-S473
Author(s):  
Deborah Gustafson ◽  
Kristoffer Bäckman ◽  
Margda Waern ◽  
Svante Östling ◽  
Xinxin Guo ◽  
...  

1982 ◽  
Vol 101 (2) ◽  
pp. 248-253 ◽  
Author(s):  
Viveca Odlind ◽  
Kerstin Elamsson ◽  
Doris E. Englund ◽  
Arne Victor ◽  
Elof D. B. Johansson

Abstract. Sex hormone binding globulin (SHBG) levels were studied for possible effects of oestradiol-17β on SHBG. No change in SHBG plasma was recorded during normal menstrual cycles or during treatment with oestradiol-17β to menopausal women. However, gonadotrophin treatment to amenorrhoeic women to induce ovulation resulted in high oestradiol concentrations and a pronounced increase in SHBG was found during the luteal phase of these cycles. A marked increase of SHBG was also recorded in a woman with pronounced fluctuations of oestradiol during treatment with levonorgestrel sc implants for contraception. In conclusion, effects on SHBG were only found when extraordinarily high levels of plasma oestradiol were recorded.


Sign in / Sign up

Export Citation Format

Share Document